K-D medical media: gentamicin, KD7.5% sodium bicarbonate, rpmi 1640 with lglutamine+ 25MMHEPES+50UG./ML.hypoxanthine (ambis #2129923)
Ended Purchase Order Awarded
- Contract number
- 75N93022P01150
- Awardee
-
K-D Medical, Inc. UEI NE9FCJ3J6SU6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,951
Award facts
- Opportunity
-
- K-D Medical Media: Gentamicin, KD7. 5% Sodium Bicarbonate, RPMI 1640 with L-Glutamine+25mMHepes+50ug. /ml. Hypoxanthine Solicitation · RFQNIAID2129923 · Posted Aug 17, 2022
- Contract value 100% obligated
- $24,950.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Columbia, MD 21045, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N93022P01150?
75N93022P01150 was awarded to K-D Medical, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 6, 2022.
How much is contract 75N93022P01150 worth?
The government has obligated $24,951 on 75N93022P01150.
Was contract 75N93022P01150 competed?
The extent of competition for 75N93022P01150 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award